
    
      The goal of this study it to validate Cipherome's drug safety score (DSS) in its predictive
      accuracy for severe adverse drug reactions (ADRs). The DSS is calculated on a scale of 0 to
      1, with preliminary studies demonstrating that scores below 0.3 correlated with a higher
      chance of an ADR and scores above 0.7 correlated with a lower chance of an ADR.
    
  